Navigation Links
Clinverse, Inc. Introduces ClinSpend to Meet Challenges of Sunshine Act Reporting Requirements
Date:6/5/2013

Raleigh, NC (PRWEB) June 05, 2013

Clinverse, Inc., a global technology and financial services company for clinical trials, today introduced its ClinSpend™ solution, designed to meet the reporting requirements to the Center for Medicare and Medicaid Services (CMS) for the federally mandated Sunshine Act, now called OPEN PAYMENTS, providing greater transparency around the financial relationships of manufacturers, physicians, and teaching hospitals.

ClinSpend is the aggregate spend reporting module within the family of products integrated seamlessly alongside Clinverse’s Financial Lifecycle System (FLS). ClinPay®, the company’s anchor product, is the industry’s leading fully-automated investigator payment system which streamlines and automates the financial payment process in clinical trials. For sponsors, clinical research organizations (CROs), and healthcare providers (HCPs) deploying ClinPay for payments, more than 90% of the research transactional data required by OPEN PAYMENTS already resides within the system. By leveraging the unified FLS platform, ClinSpend has the added capability to collect and report on payments made directly to teaching hospitals and indirectly to physicians performing research at the teaching hospital.

Whether used alone or as an integrated component to the FLS platform, ClinSpend provides HCPs access to real-time, proactive dispute resolution through its site portal to review and challenge payment claims made by applicable manufacturers. Manufacturers can proactively manage HCP relationships by verifying data and resolving discrepancies shortly after payment is made, rather than requiring the HCP to wait to file a dispute months later when data are transmitted to CMS.

Clinverse’s application programming interface (API) provides the flexibility for ClinSpend to easily accept research, non-research, and ownership data from a wide variety of additional sources, including clinical software applications and spreadsheets. One example is the recent strategic partnership agreement with Aggregate Spend Solutions, LLC, integrating the company’s flagship product, SpendMD™. SpendMD is a web-based system created to report transfer of value (TOV) associated with investigator and other meeting-related expenses. Related data are captured and easily exportable for review by the client and investigator, and are then sent to ClinSpend to be packaged with all other OPEN PAYMENTS data for submission to CMS.

“The reality is that the cost of meeting these new requirements is a burden and must be absorbed by drug, biologic, device, and manufacturers doing business in the US,” said Steve Ayala, President of Clinverse. “For many manufacturers, managing the volume of data needed for the Sunshine Act will require either a small army of resources or an automated solution. Outsourcing the data collection and integration process to a single, quality-driven solution like ClinSpend is an attractive, cost-effective alternative that allows manufacturers to focus on their core business activities.”

Clinverse will be exhibiting at DIA 2013 in Boston June 23rd – 27th. Stop by Booth #2000 for more information on ClinSpend.

About Clinverse, Inc.
Clinverse, Inc. is a global technology and financial services company that delivers highly secure, cloud-based financial management and payment solutions for the clinical trials industry. Founded in 2008 and headquartered in Raleigh, NC, the company delivers clinical financial solutions through the only truly collaborative and transparent financial management and payment platform. Used by leading BioPharma companies, Clinverse has developed ClinPay® FLS, a fully-configurable, game-changing SaaS-based platform which manages tens of millions of dollars in financial transactions for thousands of global sites while supporting payments in 140 different currencies. For more information, please visit http://www.clinverse.com.

Media Contact:
Molly Thompson, Crossroads PR, for Clinverse
919-821-2822
clinverse(at)crossroadspr(dot)com

Read the full story at http://www.prweb.com/releases/2013/6/prweb10802333.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC
2. New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
3. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
4. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
5. NextGen introduces its first generation of animal biomarker products for development of brain disorder diagnostics
6. WHEATON® Introduces a New Web Community for Scientists, Researchers, and Biopharmaceutical Packagers
7. Profit Lifter for Pro Mold Removers: Molderizer Introduces Remediation Product Like No Other
8. JPSA Introduces Picosecond Laser Micromachining System
9. Vision Research Introduces the Newest Member Of the Phantom®- 1Mpx- v-Series Camera Family
10. AllCells Introduces Autoimmune Diseased Cells and Tissue Products
11. White Mountain Process Introduces Squeal-less Mechanical Seal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , ... October 12, 2017 , ... ... two-dimensional representations of a complex biological network, a depiction of a system of ... mess,” said Dmitry Korkin, PhD, associate professor of computer science at Worcester Polytechnic ...
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a global ... industries to improve patient outcomes and quality of life, will now be offering ... being attributed to new regulatory requirements for all new drug products, including the ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for ... June 2018 in San Francisco, CA. The Summit brings together current and former FDA ... board directors and government officials from around the world to address key issues in ...
(Date:10/11/2017)... ... 2017 , ... A new study published in Fertility and ... in vitro fertilization (IVF) transfer cycles. The multi-center matched cohort study ... comparing the results from the fresh and frozen transfer cohorts, the authors of ...
Breaking Biology Technology:
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. ... company, announces the filing of its 2016 Annual Report on Form ... Exchange Commission. ... Form 10-K is available in the Investor Relations section of the ... on the SEC,s website at http://www.sec.gov . 2016 ...
(Date:4/11/2017)... PALM BEACH GARDENS, Fla. , April 11, ... biometric identity management and secure authentication solutions, today ... million contract by Intelligence Advanced Research Projects Activity ... technologies for IARPA,s Thor program. "Innovation ... the onset and IARPA,s Thor program will allow ...
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
Breaking Biology News(10 mins):